Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 2 4Phase 4 3Phase 1 2

Status

Unknown 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Leukemia, Myeloid, Acute 6Leukemia, Promyelocytic, Acute 3Philadelphia Chromosome 1Neoplasm, Residual 1Myelodysplastic Syndromes 1Lymphoma, Large B-Cell, Diffuse 1Burkitt Lymphoma 1

Interventions

Idarubicin 3Arsenic Trioxide 3Mitoxantrone 2Cytarabine 2Tretinoin 1Transplantation, Autologous 1Thiotepa 1Radiotherapy 1Filgrastim 1Daunorubicin 1Cyclophosphamide 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Leukemia, Promyelocytic, Acute × Idarubicin × Clear all
NCT01987297 2019-08-19

Combined Retinoic Acid,Arsenic Trioxide and Chemo for Newly-diagnosed APL

Shanghai Jiao Tong University School of Medicine

Phase 4 Unknown
738 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

NCT00408278 2014-10-28

Treatment of Newly Diagnosed Patients With Acute Promyelocytic Leukemia (PETHEMA LPA 2005)

PETHEMA Foundation

Phase 4 Completed
300 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

NCT00180128 2011-07-11

AIDA2000 - Risk-Adapted Therapy for Patients With Acute Promyelocytic Leukemia

Technische Universität Dresden

Phase 4 Unknown
80 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡